Page last updated: 2024-11-06

6,6'-dithiodinicotinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6,6'-dithiodinicotinic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID85040
CHEMBL ID1161936
SCHEMBL ID147705
MeSH IDM0041192

Synonyms (51)

Synonym
einecs 239-729-6
brn 0426589
ai3-62508
nsc 147758
6,6'-dithiobis-3-pyridinecarboxylic acid
6-[(5-carboxy-2-pyridyl)disulfanyl]pyridine-3-carboxylic acid
6, 6'-dithionicotinic acid
nicotinic acid, 6,6'-dithiodi-
3-pyridinecarboxylic acid, 6,6'-dithiobis-
6, 6-dithiodinicotinic acid
NCGC00014393
3-pyridinecarboxylic acid,6'-dithiobis-
6,6'-dithiodinicotinic acid
nicotinic acid,6'-dithiodi-
6,6-dithiodinicotinic acid
nsc147758 ,
6,6'-dithionicotinic acid
carboxypyridine disulfide
nsc-147758
cpds
15658-35-2
6,6'-dithiodinicotinic acid, technical grade, 85%
NCI147758
NCI60_001011
NCISTRUC1_001825
NCISTRUC2_001273
NCGC00097500-01
D2564
6,6'-dithiobis(3-pyridinecarboxylic acid)
CHEMBL1161936
6-[(5-carboxypyridin-2-yl)disulfanyl]pyridine-3-carboxylic acid
5-22-05-00117 (beilstein handbook reference)
CCG-37163
NCGC00014393-02
FT-0637256
AKOS015892318
BP-30136
SCHEMBL147705
GSASOFRDSIKDSN-UHFFFAOYSA-N
DTXSID40166098
mfcd00006454
AS-65400
6,6'-dithiobis[3-pyridinecarboxylic acid]
J-009318
6,6'-disulfanediyldinicotinic acid
6,6/'-dithiodinicotinic acid
carboxypyridine-disulfide
D90084
6,6 inverted exclamation marka-dithiodinicotinic acid
CS-0318486
HY-W273281
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency0.81750.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency0.81750.025120.237639.8107AID886; AID893
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency4.46680.011212.4002100.0000AID1030
cytochrome P450 2C19 precursorHomo sapiens (human)Potency2.51190.00255.840031.6228AID899
cytochrome P450 2C9 precursorHomo sapiens (human)Potency1.58490.00636.904339.8107AID883
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency3.98110.001815.663839.8107AID894
lethal factor (plasmid)Bacillus anthracis str. A2012Potency5.01190.020010.786931.6228AID912
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency1.58490.00638.235039.8107AID883
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Replicase polyprotein 1abBetacoronavirus England 1IC50 (µMol)10.00000.00403.43889.5100AID1640022
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)0.24000.00022.45859.9600AID1640021
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID284123Herbicidal activity against Brassica campestris L assessed as inhibition of rape root growth at 100 ug/ml2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.
AID284122Inhibition of Arabidopsis thaliana AHAS2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.
AID284124Herbicidal activity against Brassica campestris L assessed as inhibition of rape root growth at 10 ug/ml2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (57.14)18.7374
1990's5 (23.81)18.2507
2000's2 (9.52)29.6817
2010's2 (9.52)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.32 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]